Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Subjects With Gastroparesis
NCT00845858 is registered in ClinicalTrials.gov with Evoke Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Subjects With Gastroparesis
- Lead sponsor
- Evoke Pharma
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- December 31, 2011
- Enrollment
- 287 (actual)
- Sites
- 65
Conditions
As the registry lists them; a condition with its own page is linked.
delayed gastric emptying, diabetes, diabetes mellitus, diabetic gastroparesis, gastroparesis